drug data

Pharma

FibroGen admits to manipulating data for anemia drug roxadustat

FibroGen admitted to presenting doctored data on roxadustat, prompting analysts to reassess the anemia drug's prospects ahead of an FDA decision.
Angus Liu Apr 7, 2021 9:50am

AveXis knew of Zolgensma's latest safety flag since March

Oct 31, 2019 11:42am

Novartis to FDA: AveXis execs doctored Zolgensma data

Sep 24, 2019 12:37pm

Does Novartis' delay in probing data manipulation spell trouble?

Aug 23, 2019 11:47am

Novartis CEO (sort of) admits mishandling Zolgensma crisis

Aug 19, 2019 11:38am

Novartis' Zolgensma data rigging draws Senators' ire

Aug 12, 2019 12:02pm